Your browser doesn't support javascript.
loading
Extended Safety and Tolerability of Darolutamide for Nonmetastatic Castration-Resistant Prostate Cancer and Adverse Event Time Course in ARAMIS.
Shore, Neal D; Gratzke, Christian; Feyerabend, Susan; Werbrouck, Patrick; Carles, Joan; Vjaters, Egils; Tammela, Teuvo L J; Morris, David; Aragon-Ching, Jeanny B; Concepcion, Raoul S; Emmenegger, Urban; Fleshner, Neil; Grabbert, Markus; Lietuvietis, Vilnis; Mahammedi, Hakim; Cruz, Felipe M; Paula, Adriano; Pieczonka, Christopher; Rannikko, Antti; Richardet, Martin; Silveira, Glauco; Kuss, Iris; Le Berre, Marie-Aude; Verholen, Frank; Sarapohja, Toni; Smith, Matthew R; Fizazi, Karim.
Affiliation
  • Shore ND; Carolina Urologic Research Center, Myrtle Beach, SC, USA.
  • Gratzke C; Department of Urology, University Hospital Freiburg, Freiburg, Germany.
  • Feyerabend S; Studienpraxis Urologie, Nürtingen, Germany.
  • Werbrouck P; Department of Urology, AZ Groeninge, Kortrijk, Belgium.
  • Carles J; Vall d'Hebron Institute of Oncology, Hospital Universitari Vall d'Hebron, Barcelona, Spain.
  • Vjaters E; Urological Center, Pauls Stradins Clinical University Hospital, Riga, Latvia.
  • Tammela TLJ; Department of Urology, Tampere University Hospital and Tampere University, Tampere, Finland.
  • Morris D; Urology Associates, PC, Nashville, TN, USA.
  • Aragon-Ching JB; Inova Schar Cancer Institute, Fairfax, VA, USA.
  • Concepcion RS; Urology Associates, PC, Nashville, TN, USA.
  • Emmenegger U; Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, Canada.
  • Fleshner N; Odette Cancer Centre, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, Canada.
  • Grabbert M; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.
  • Lietuvietis V; Department of Urology, University Hospital Freiburg, Freiburg, Germany.
  • Mahammedi H; Urology Clinic, Department of Surgery, Riga East Clinical University Hospital, Riga, Latvia.
  • Cruz FM; Medical Oncology, Jean Perrin Center, Clermont-Ferrand, France.
  • Paula A; Núcleo de Ensino e Pesquisa da Rede São Camilo, São Paulo, Brazil.
  • Pieczonka C; Oncologic Surgery, Hospital Araújo Jorge, Goiânia, Brazil.
  • Rannikko A; Associated Medical Professionals, Syracuse, NY, USA.
  • Richardet M; Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland.
  • Silveira G; Oncologic Institute of Córdoba, Sanatorio Aconcagua, Córdoba, Argentina.
  • Kuss I; Centro Oncológico do Triângulo, Uberlândia, Brazil.
  • Le Berre MA; Bayer AG, Berlin, Germany.
  • Verholen F; Bayer HealthCare SAS, Loos, France.
  • Sarapohja T; Bayer Consumer Care AG, Basel, Switzerland.
  • Smith MR; Orion Pharma, Espoo, Finland.
  • Fizazi K; Massachusetts General Hospital Cancer Center, Boston, MA, USA.
Oncologist ; 29(7): 581-588, 2024 Jul 05.
Article in En | MEDLINE | ID: mdl-38394384
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pyrazoles / Prostatic Neoplasms, Castration-Resistant Limits: Aged / Aged80 / Humans / Male / Middle aged Language: En Journal: Oncologist Journal subject: NEOPLASIAS Year: 2024 Document type: Article Affiliation country: Estados Unidos Country of publication: Reino Unido
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pyrazoles / Prostatic Neoplasms, Castration-Resistant Limits: Aged / Aged80 / Humans / Male / Middle aged Language: En Journal: Oncologist Journal subject: NEOPLASIAS Year: 2024 Document type: Article Affiliation country: Estados Unidos Country of publication: Reino Unido